相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Playing polo during mitosis: PLK1 takes the lead
G. Combes et al.
ONCOGENE (2017)
Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review
Yuling Liu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
Rosie Elizabeth Ann Gutteridge et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers
Bilal Bin Hafeez et al.
CANCER PREVENTION RESEARCH (2015)
Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma
Shinya Ohashi et al.
GASTROENTEROLOGY (2015)
Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression
Mingshan Niu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Induction of apoptosis and autophagy via sirtuinI- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells
Zhi-Wei Zhou et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells
Yan-Cong Li et al.
CANCER LETTERS (2014)
Plk1 Inhibition Enhances the Efficacy of Androgen Signaling Blockade in Castration-Resistant Prostate Cancer
Zhe Zhang et al.
CANCER RESEARCH (2014)
Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State
Zhiguo Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches
Mohammad S. Jamal et al.
PLOS ONE (2014)
Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo
Sutapa Sinha et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Epidemiology of Esophageal Cancer in Japan and China
Yingsong Lin et al.
JOURNAL OF EPIDEMIOLOGY (2013)
Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model
Bilal Bin Hafeez et al.
MOLECULAR ONCOLOGY (2013)
Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions
Wei Yan et al.
BONE RESEARCH (2013)
Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2
Li Lai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Reciprocal Activation Between PLK1 and Stat3 Contributes to Survival and Proliferation of Esophageal Cancer Cells
Yu Zhang et al.
GASTROENTEROLOGY (2012)
Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-?B signaling pathways
Bilal Bin Hafeez et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Plumbagin Inhibits Osteoclastogenesis and Reduces Human Breast Cancer-Induced Osteolytic Bone Metastasis in Mice through Suppression of RANKL Signaling
Bokyung Sung et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Apoptosis Inducing Effect of Plumbagin on Colonic Cancer Cells Depends on Expression of COX-2
Bharathi Raja Subramaniya et al.
PLOS ONE (2011)
Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics
Puneet Chopra et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Klaus Strebhardt
NATURE REVIEWS DRUG DISCOVERY (2010)
BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
Dorothea Rudolph et al.
CLINICAL CANCER RESEARCH (2009)
Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma
Yan-Bin Feng et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Polo-like kinases: conservation and divergence in their functions and regulation
Vincent Archambault et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Plumbagin, a Medicinal Plant-Derived Naphthoquinone, Is a Novel Inhibitor of the Growth and Invasion of Hormone-Refractory Prostate Cancer
Moammir H. Aziz et al.
CANCER RESEARCH (2008)
Plumbagin-induced Apoptosis in Human Prostate Cancer Cells is Associated with Modulation of Cellular Redox Status and Generation of Reactive Oxygen Species
Anna A. Powolny et al.
PHARMACEUTICAL RESEARCH (2008)
BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo
Martin Steegmaier et al.
CURRENT BIOLOGY (2007)
Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells
Po-Lin Kuo et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo
Ya-Ling Hsu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA
XQ Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
